|4Apr 12, 6:01 PM ET

Girao Tiago 4

4 · Landos Biopharma, Inc. · Filed Apr 12, 2021

Insider Transaction Report

Form 4
Period: 2021-04-08
Girao Tiago
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-08+36,00036,000 total
    Exercise: $10.16Exp: 2031-04-07Common Stock (36,000 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this option will vest and become exercisable in 36 equal monthly installments beginning on April 8, 2021, subject to the Reporting Person's continuous service with the Issuer on each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION